BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35993245)

  • 1. HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension.
    Ruffenach G; Medzikovic L; Aryan L; Li M; Eghbali M
    Circulation; 2022 Oct; 146(16):1243-1258. PubMed ID: 35993245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
    J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension.
    Courboulin A; Tremblay VL; Barrier M; Meloche J; Jacob MH; Chapolard M; Bisserier M; Paulin R; Lambert C; Provencher S; Bonnet S
    Respir Res; 2011 Sep; 12(1):128. PubMed ID: 21951574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
    Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of YTHDF1 prevents hypoxia-induced pulmonary artery smooth muscle cell proliferation by regulating Foxm1 translation in an m6A-dependent manner.
    Kang T; Liu L; Tan F; Zhang D; Yu L; Jiang H; Qian W; Hua J; Zheng Z
    Exp Cell Res; 2023 Mar; 424(2):113505. PubMed ID: 36736607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
    Wang L; Moonen JR; Cao A; Isobe S; Li CG; Tojais NF; Taylor S; Marciano DP; Chen PI; Gu M; Li D; Harper RL; El-Bizri N; Kim YM; Stankunas K; Rabinovitch M
    Circ Res; 2023 Mar; 132(5):545-564. PubMed ID: 36744494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified Fangji Huangqi decoction ameliorates pulmonary artery hypertension via phosphatidylinositide 3-kinases/protein kinase B-mediated regulation of proliferation and apoptosis of smooth muscle cells in vitro and in vivo.
    Xue Z; Zhou M; Liu Y; Qin H; Li Y; Zhu Y; Yang J
    J Ethnopharmacol; 2023 Oct; 314():116544. PubMed ID: 37088239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
    Wu YC; Wang WT; Yang MC; Su YT; Yeh JL; Hsu JH; Wu JR
    Biol Res; 2023 Dec; 56(1):66. PubMed ID: 38057829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
    Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L
    Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt-related pulmonary arterial hypertension.
    Zhou JJ; Yang J; Li L; Quan RL; Chen XX; Qian YL; Huang L; Wang PH; Li Y; Meng XM; Chen X; Gu Q; He JG
    ESC Heart Fail; 2022 Oct; 9(5):3407-3417. PubMed ID: 35841124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
    Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
    Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
    Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension.
    Miao R; Liu W; Qi C; Song Y; Zhang Y; Fu Y; Liu W; Lang Y; Zhang Y; Zhang Z
    Life Sci; 2020 Sep; 257():117919. PubMed ID: 32585247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nur77 suppresses pulmonary artery smooth muscle cell proliferation through inhibition of the STAT3/Pim-1/NFAT pathway.
    Liu Y; Zhang J; Yi B; Chen M; Qi J; Yin Y; Lu X; Jasmin JF; Sun J
    Am J Respir Cell Mol Biol; 2014 Feb; 50(2):379-88. PubMed ID: 24047441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.